News


US Patent Granted! – 08.09.2020

US Patent Granted! – 08.09.2020


Posted on Sep 15, 2020 in News

We are proud to announce the latest development of our company, KYLYS. Our patent has been granted in the US for our unique technology: HA Pearls! We are so excited about our upcoming development activities in various applications. We hope you will follow our journey and stay tuned!

Read More
Innosuisse project – 09.05.2020

Innosuisse project – 09.05.2020


Posted on May 9, 2020 in News

KYLYS was granted an Innosuisse project to develop HA Pearls product towards novel therapeutic application. This project is in collaboration with the University of Geneva.

Read More
International patent – 11.09.2019

International patent – 11.09.2019


Posted on Sep 11, 2019 in News

KYLYS is pleased to announce that its main patent application filed under the Patent Cooperation Treaty (PCT) convention recently entered the national phases. This is an important step toward protecting KYLYS’s invention in multiple countries worldwide.

Read More
Bioinnovation day – 15.11.2018

Bioinnovation day – 15.11.2018


Posted on Dec 1, 2018 in News

We are very proud to have been selected by the BioInnovation Day 2018 organization to present our project HA Pearls. The 8th edition of BioInnovation Day took place on 15 November 2018 at Geneva’s Life Sciences Hub Campus Biotech, providing an opportunity for researchers, scientist-entrepreneurs and early-stage start-up ventures to pitch their projects to an audience of peers, investors, and industry representatives....

Read More

KYLYS is assigned exclusive worldwide rights by University of Geneva on an innovative technology based on hyaluronic acid (HA). HA, a naturally occurring biocompatible molecule found throughout the body that is a vital component of healthy joint and tissue...

Read More